Investors

Events and Presentations

Analyst Coverage

Corporate Governance

Publication Archive

Investor Contacts & Alerts

News Releases

Sep 21, 2018

New Data on Patient Acceptability and Genitourinary Effects of Evofem Biosciences' Amphora and its Role as a Multipurpose Vaginal pH Regulator (MVP-R) to be Presented at the 2018 American Society For Reproductive Medicine (ASRM) Annual Congress
Sep 18, 2018

Evofem Biosciences to Present at Upcoming Investor Conferences
Aug 29, 2018

Rise in Prevalence of STDs Reported by CDC Supports Continued Development of Novel Solutions, Like Evofem's Product in Development, Amphora®, for the Prevention of Chlamydia
Aug 23, 2018

Evofem Biosciences to Present at 20th Annual Global Investment Conference on September 6, 2018
Aug 7, 2018

Evofem Biosciences' Chief Medical Officer, Dr. Kelly Culwell, to Present at #BlogHer18 Creators Summit
Aug 2, 2018

Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Phase 3 Trial of Amphora for Hormone-free Contraception Continues to Move Ahead of Schedule; Top Line Data now expected in Late 2018
Jul 19, 2018

Evofem Biosciences to Report Second Quarter 2018 Results and Provide Corporate Update on August 2, 2018

-- Conference Call Scheduled for 11:00 a.m. EDT --
May 29, 2018

Evofem Biosciences to Present at Jefferies Global Healthcare Conference on June 7, 2018
May 24, 2018

Evofem Biosciences Announces Closing of Public Offering of Common Stock and Warrants
May 22, 2018

Evofem Biosciences Announces Pricing of Public Offering of Common Stock and Warrants

Show per page